Dawn of Disruption: Ad Tech M&A Frenzy and Venue Visions Light Up Tuesday’s Tape

DENVER, Colo., Sep 24, 2025 (247marketnews.com)- Good morning. As markets open, here’s what’s catching attention in overlooked and speculative names, and what to watch today.

VENU (NYSE:VENU) announced the November 19 groundbreaking for the 12,500-seat Sunset Amphitheater at El Paso, backed by $31.5 million incentives and a $2 billion decade-long economic jolt. CEO J.W. Roth beamed, “This groundbreaking… is the start of a transformative journey,” with Mayor Renard U. Johnson adding it “positions El Paso as a stronger regional destination.” Luxe FireSuites and Aikman Club (156 elite members) promise year-round luxe, amplifying VENU’s $5 billion pipeline.

SHF Holdings (NASDAQ:SHFS), a cannabis banking disruptor exploded after-hours to on a $150 million stock purchase pact with CREO Investments, providing flexible firepower for its fully managed compliance program amid a $30 billion U.S. cannabis sector (21% CAGR to 2030, Prohibition Partners). Trading flipped bullish as CEO Terry Mendez preps for the PBC Conference today, spotlighting “conscious capitalism” in psychedelics. With $15 million Q2 revenue despite -$18 million equity, this lifeline could fuel 2026 loan servicing growth.

Bakkt (NASDAQ:BKKT) is extending its weekly tear, which started after redeeming its $150 million convertible debenture and nabbing a 30% stake in Japan’s MarushoHotta for blockchain payments expansion. Amid a $2 trillion crypto market rebound, BKKT’s debt wipeout, slashing long-term obligations to zero, bolsters its API solutions for 401(k) crypto pilots (per recent Trump EO). “We’re transforming into a blockchain-native payments leader,” management stated, with shares up 300% from August lows as Q3 volumes hit $1.2 billion.

UniQure (NASDAQ:QURE), a biotech gene therapy play, soared after Mizuho upgraded to Outperform with a $30 target, citing AMT-130’s BLA path alignment and topline three-year data due this month. With $377 million cash into H2 2027, uniQure’s Q2 loss narrowed to $0.69/share from $1.16, as CEO Matt Kapusta noted, “We’re well-positioned for the first disease-modifying therapy.” Fabry disease enrollment advances, with Phase I/IIa data at ICIEM Kyoto on September 5.

Energy Fuels (NYSE:UUUU), a uranium / nuclear materials‑oriented name, gained on a Vulcan Elements pact for domestic rare earth magnets, bypassing China in a $10 billion EV supply chain (25% CAGR). Q2 mined 639,000 pounds from Pinyon Plain, with director sales ($146K-$148K) amid 240% six-month returns; White Mesa Mill eyes commercial heavy REE oxides by Q4 2026.

ClearPoint Neuro (NASDAQ:CLPT), which operates in the medical device / neurosurgical guidance space, rose on FDA’s 1.5T MRI expansion for Prism Laser Therapy, unlocking 60% of U.S. scanners and 70% globally in a $15 billion neuro-oncology space. Q2 revenue hit $9.2 million (17% YoY), reaffirming $36-41 million 2025 guidance, as CEO Joe Burnett said it “aligns with our growth initiatives.”

GDS Holdings (NASDAQ:GDS), which operates data centers / digital infrastructure in China, climbed after Raymond James reiterated Strong Buy ($50 target) on AI hyperscaler demand, with Q2 revenue beating at $2.9 billion (EPS loss $0.06 vs. -$0.39 expected). C-REIT trading debut (August 8) and new REIT guidelines signal $5 billion capex pipeline in a $300 billion Asia-Pacific sector.

IREN (NASDAQ:IREN), a Bitcoin miner and AI cloud provider, leaped on H.C. Wainwright’s $36 target hike, fueled by 50 EH/s mining capacity (+400% YoY) and 1.9k NVIDIA GPUs for $200-250 million AI revenue by December. Q4 FY25 net income flipped to $177 million, with co-CEO Daniel Roberts’ $33 million share sale (September 11) underscoring conviction amid 366% six-month gains.

About Venu Holding Corporation

Venu Holding Corporation (NYSE American: VENU) is redefining the live entertainment landscape through a national network of premium amphitheaters powered by its Luxe FireSuites model. With partnerships like AEG and Aramark, and an active development pipeline of over $5 billion (including $1 billion underway), Venu is building the next generation of destination venues, where investors, fans, and artists come together in a hospitality-first experience.

Please click here to read Cenorium’s full Venu analyst report on 247marketnews.com.

For the full 24/7 Market News VENU report and in-depth insights, visit: Read 24/7 Market News VENU Report/

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by paid by Microcap Advisory for providing ongoing XHLD market outreach and other services. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/ or go to https://247marketnews.com/ten-holdings-event-solutions/ for additional 247marketnews.com XHLD disclosure. 247 has been paid by Microcap Advisory for providing ongoing XHLD market outreach and other services. This press release may include technical analysis for instructional purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (XHLD, SHFS, BKKT, UUUU, CLPT, IREN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.